Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon

Recruiting N/A Interventional Study
Cervical Cancer Screening HIV
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 – 49
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
1,422 (estimated)
Sponsor
Institut de Recherche pour le Developpement · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Context. Cervical cancer (CC) is a leading cause of death among women living with HIV (WLHIV) in resource-limited settings. Yet, effective methods for screening and preventing CC are available. The recommanded approach for CC screening is based on multiple steps, including initial test to detect human papillomavirus (HPV) infection, visual inspection to identify women with HPV at risk for precance…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * HIV infection * receiving antiretroviral therapy * living in the department of the study hospital Exclusion Criteria: * ongoing pregnancy * hysterectomy * treatment of cervical lesion in the past 12 months * Expected follow-up difficulties: planned absence that could interfe…
Contacts

Andre-Pascal Goura, MD

+227679336464

cdpoptitri@gmail.com

CONTACT